Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Directorate Change

23 Jul 2015 13:35

RNS Number : 9253T
Imperial Innovations Group plc
23 July 2015
 



23 July 2015

 

Imperial Innovations Group plc

 

Directorate Change

 

Imperial Innovations Group plc (AIM: IVO, 'the Group', 'Innovations') announces that its non-executive director Mark Rowan will resign from the Board on 31 July 2015.

 

Mark was appointed to the Board in April 2006, having been a director of the Group's subsidiary Imperial Innovations Ltd since January 2005. He joined Innovations after a career working at J.P. Morgan and American International Group and has also provided advice on strategic and structural issues to a broad spectrum of companies, including early-stage technology investments.

 

Mark served as the Chairman of the Group's Audit and Risk Committee since the Group's IPO in 2006. He also served on the Remuneration Committee and Nomination Committee.

 

Linda Wilding takes over as chair of the Audit and Risk Committee on 1 August 2015.

 

Martin Knight, Chairman of Imperial Innovations, said:

 

"On behalf of the Board I would like to thank Mark for more than ten years of service to the Group, during which time we have benefited from his extensive experience, wise counsel and financial expertise.

 

"He has played an important role in Innovations' evolution, from its IPO in 2006, to its current position as one of the UK's leading technology commercialisation companies.

 

"His legacy includes our sound financial controls and funding strategy, recent highlights of which include the execution of last year's £150m placing and obtaining £80m in loan facilities from the European Investment Bank (EIB).

 

"Mark has made a significant contribution to the success of the Group and we would all like to thank him for his service and offer him our best wishes for the future."

 

For further information contact:

 

Imperial Innovations Group plc

020 3053 8834

Martin Knight, Chairman

Jon Davies, Director of Communications

 

Instinctif Partners

020 7457 2020

Adrian Duffield/Melanie Toyne-Sewell

 

J.P. Morgan Cazenove (Nominated Adviser)

020 7742 4000

Michael Wentworth-Stanley/Alec Pratt

 

Cenkos Securities

020 7397 8900

Christopher Golden

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGUCWMUPAGPW
Date   Source Headline
26th Oct 20077:24 amPRNGBP30m Placing
27th Sep 20077:04 amRNSInvestment in EVO Electric
27th Sep 20077:00 amPRNFinal Results
24th Sep 20072:44 pmRNSThe Engineer Awards
12th Sep 20078:00 amPRNNotice of Preliminary Results
31st Aug 20079:00 amRNSInvestment in MVL
7th Aug 20079:00 amRNSionscope raises funds
3rd Aug 200710:25 amRNSInvestment in Veryan Medical
3rd Aug 20078:00 amRNSInvestment in Veryan Medical
1st Aug 20075:31 pmRNSInvestment in Nexeon Ltd
30th Jul 20078:00 amRNSInvestment in Acrobot Ltd
11th Jul 20079:37 amRNSInvestment in AML
6th Jul 20078:10 amRNSInvestment in NanoBioDesign
28th Jun 20077:02 amRNSInvestment in QuantaSol
25th Jun 200710:00 amRNSCall For Recycling Inventions
20th Jun 200711:21 amRNSInvestment in PolyTherics
14th Jun 20072:31 pmRNSInvestment in Midaz Lasers
6th Jun 20073:11 pmRNSPSE Wins MacRobert Award
5th Jun 200711:03 amRNSPSE - Awards Finalist
23rd May 20078:00 amRNSInvestment in IXICO Ltd
11th May 200710:00 amRNSInvestment in Veryan Medical
9th May 200710:04 amRNSMDi Licensing Deal
27th Apr 20077:01 amRNSLaunch of Funding Programme
27th Apr 20077:01 amRNSInterim Results
30th Mar 20078:00 amRNSInvestment in Cell Medica
27th Mar 200710:22 amRNSStormBio Licensing Deal
23rd Mar 20078:00 amRNSNotice of Results
22nd Mar 200711:53 amRNSHolding(s) in Company
16th Mar 200710:44 amRNSHolding(s) in Company
15th Mar 20079:00 amRNSIncubation of Stoneglass
12th Mar 20078:00 amRNSIonscope Sells First Products
8th Mar 20079:20 amRNSHolding(s) in Company
7th Mar 20078:00 amRNSChinese Strategic Partnership
13th Feb 20078:00 amRNSIncubation of Rubber-Regen
9th Feb 20073:05 pmRNSHolding(s) in Company
8th Feb 20072:58 pmRNSHolding(s) in Company
1st Feb 20077:00 amRNSInvestment in ATT Ltd
29th Jan 20077:01 amRNSInvestment in Circassia
25th Jan 200712:59 pmRNSResult of AGM
12th Jan 20079:00 amRNSInvestment in Equinox Pharma
21st Dec 200612:13 pmRNSTotal Voting Rights
18th Dec 20064:53 pmRNSHolding(s) in Company
8th Dec 20067:00 amRNSAnnual Report and Accounts
21st Nov 20067:01 amRNSDirector/PDMR Shareholding
16th Nov 20067:01 amRNSBAE Systems Contract
16th Nov 20067:01 amRNSFinal Results
2nd Nov 20068:00 amRNSImperial BioIncubator
26th Oct 20067:01 amRNSNotice of Results
23rd Oct 20064:17 pmRNSDisposal
18th Oct 20067:00 amRNSLow Carbon Seed Fund

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.